تا بعدی

پخش خودکار

Phase II trial show nilotinib achieves remission Philadelphia-positive acute lymphocytic leukaemia

7 بازدیدها • 08/04/23
اشتراک گذاری
جاسازی کنید
administrator
administrator
مشترکین
0

At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Oliver Ottmann (Goethe-University Hospital, Frankfurt, Germany) discusses a Trial of the European Working Group for Adult ALL (EWALL-PH-02), which evaluated nilotinib and chemotherapy for first-line treatment in elderly patients with de novo Philadelphia chromosome/BCR-ABL1-positive acute lymphoblastic leukaemia.

بیشتر نشان بده، اطلاعات بیشتر
0 نظرات sort مرتب سازی بر اساس
نظرات فیس بوک

تا بعدی

پخش خودکار